Theranostics, Gallium-68, and Other Radionuclides

A Pathway to Personalized Diagnosis and Treatment

Inbunden, Engelska, 2012

AvRichard P. Baum,Frank Rösch,MD Baum, Richard P.,Frank Rosch

3 059 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

This book is based on contributions presented at the 1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy, which examined recent developments in theranostics – the emerging field of molecular targeting of vectors that can be used for both diagnosis and therapy, when modified accordingly.

Produktinformation

Utgivningsdatum2012-08-23
Mått155 x 235 x 37 mm
Vikt1 012 g
FormatInbunden
SpråkEngelska
SerieRecent Results in Cancer Research
Antal sidor578
Upplaga2013
FörlagSpringer-Verlag Berlin and Heidelberg GmbH & Co. KG
ISBN9783642279935

Tillhör följande kategorier

Onkologi inom Medicin
Nuklearmedicin inom Medicin
Medicinsk utrustning och medicinska tekniker inom Medicin
Medicinsk bildbehandling inom Medicin

From the contents: Ge-68/Ga-68 generators.- Automation strategies in Ga-68 radiopharmaceutical preparations.- Post-processing via cation exchange cartridges.- Gallium-68 generator integrated system: elution – purification - concentration integration.- Purification and labelling strategies for 68Ga from 68Ge/68Ga generator eluate.- 67Ga and 68Ga purification studies.- The diversity of [68Ga]Ga-based imaging agents.- Nanoparticles and phage display selected peptides for imaging and therapy of cancer.- “Click” cyclized gallium-68 labeled peptides for molecular imaging and therapy: Synthesis and preliminary in vitro and in vivo evaluation in a melanoma model system.- Early experience with 68Ga-DOTATATE preparation .- 68Ga-radiopharmaceuticals for PET imaging of infection and inflammation.- 68Ga-labeled bombesin analogs for receptor mediated imaging.- A novel 68Ga-labelled pteroic acid-based PET tracer for tumour imaging via the folate receptor.- Measurement of protein synthesis: In vitro comparison of 68Ga-DOTA-puromycin, [3H]tyrosine and 2-fluoro-[3H]tyrosine.- Hypoxia imaging agents labeled with positron emitters.- Lu-177/Y-90 intermediate affinity monoclonal antibodies targeting EGFR and HER2/c-neu: preparation and preclinical evaluation.- Divergent role of 68Ga labeled somatostatin analogs in the work-up of patients with NETs.- Differential uptake of 68Ga-DOTATOC and 68Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumours.

From the reviews: "The general themes of this book (theranostics and peptide receptor-targeted radiotherapy) derive from evolving successes in the use of generator-produced 68Ga for molecular imaging of disease. ... This book is an excellent resource for investigators interested in gaining a detailed understanding of the state of the art in 68Ga and peptide receptor radionuclide therapy-based theranostics for preclinical and emerging clinical applications." (Michael K. Schultz, The Journal of Nuclear Medicine, Vol. 54 (4), April, 2013)

Du kanske också är intresserad av

Clinical Use of Antibodies

European Association of Nuclear Medicine, Deutsche Gesellschaft Fur Nuklearmedizin, Richard P. Baum, etc., MD Baum, Richard P., P.H. Cox, Richard P Baum, Peter H Cox, P H Cox, Gustav Hc6r, Gian Luigi Buraggi, Gustav Hvr, Gustav Har